ATLANTA,
Aug. 9,
2024 /PRNewswire/ -- Core Access Surgical
Technologies, Inc. (CAST) is pleased to announce that its
innovative CAST LevaLap® 1.0 will be presented at
the 2024 American Association of Gynecologic Laparoscopists (AAGL)
53rd Global Congress on MIGS, held in New
Orleans, Louisiana, from Nov. 16-19,
2024. The Abstract for LevaLap® 1.0 has been
accepted for oral presentation to the attendees of this prestigious
event.
After rigorous peer review and criteria for
inclusion at the Global Congress, CAST has been chosen to unveil
the breakthrough data of the company's Post Market Clinical
Follow-Up Study for LevaLap® 1.0. The study featured a
world-class group of key physician opinion leaders and hospitals
across six countries and eight medical centers, both university and
major private centers. This underscores CAST's commitment to
advance surgical access solutions, appropriately test and evaluate
them, and to support the global medical community.
The innovation behind LevaLap®
incorporates a significant advancement in speed and efficiency of
precise laparoscopic access, offering new opportunities for
standardized abdominal entry. This advancement is set to transform
the landscape of minimally invasive laparoscopic entry across
multiple fields, including gynecology, urology, general surgery,
and robotic surgery.
"The honor of presenting our data is a
significant milestone for everyone at CAST Surgical.
LevaLap® 1.0 is our inaugural solution, and CAST's team
of experts have begun attending top educational congresses around
the world to continue the discussion with the medical community.
The good news we are sharing with the world is a device that offers
stable and more precise laparoscopic access is here now." –
Thomas A. Gordy, Chairman and Chief
Executive Officer.
About CAST Surgical
CAST is a US-based,
global medical device company that designs, develops, manufactures,
and distributes laparoscopic surgery access tools to allow
precision, mitigate risk, and standardize efficient timely access.
Our mission is to bring to the medical community superior and
innovative solutions that provide unique value, both clinically and
economically. More information is available at
www.castsurgical.com.
About AAGL
AAGL is the largest medical
society focused on gynecologic surgery, with an international
membership of over 7,100 physicians and healthcare providers
committed to advancing minimally invasive gynecologic surgery
(MIGS). AAGL's Annual Global Congress is the premier scientific
program that provides the world's finest gynecologic surgeons with
the latest education and best practices in MIGS.
Contacts
For investor inquiries please contact:
Thomas A. Gordy, Chairman and Chief
Executive Officer, tgordy@castsurgical.com
For media inquiries please contact:
CAST Surgical, +1-770-328-6642
www.castsurgical.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cast-surgical-chosen-to-unveil-breakthrough-clinical-follow-up-data-at-2024-aagl-global-congress-on-migs-302218960.html
SOURCE Core Access Surgical Technologies, Inc.